Behavior, HealthNCT05787548
Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options
A study testing Contact information, Urgent care map and Self-triage chart in people with Behavior, Health, run by Geisinger Clinic at 1 site in United States.
Trial summary
Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Behavior, Health
- What is being tested?
- Contact information, Urgent care map and Self-triage chart
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 239,841 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Apr 2023to 11 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age 18+
- Has a Geisinger Primary Care Physician assigned
- Completes an outpatient office visit or telemedicine appointment at Geisinger
Who cannot join
- The AVS was not printed according to the EHR, and the patient does not have an active MyGeisinger patient portal account, so they do not have a way to view the AVS
Trial locations and contacts
1 site in 1 country.
About this study
Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. The study team is working to reduce ED utilization by including additional information in adult outpatient After Visit Summaries (AVSs). The study will involve will involve A/B testing different AVS versions, including 1) a version that encourages patients to contact Geisinger via different contact methods, 2) a version that includes a map to the patient's closest ConvenientCare location and accompanying information about ConvenientCare, and 3) a version that includes a self-triage guide. A control group will receive the current standard AVS. Analysis results will be assessed to determine which version is most effective at reducing ED use.
- Conditions
- Behavior, Health
- Being tested
- Contact information, Urgent care map, Self-triage chart
- Keywords
- Emergency Department Use, Urgent Care Use
- Medical subject headings
- Health Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Contact informationBehavioural
Information on how to contact Geisinger if the patient needs care
Urgent care mapBehavioural
A map of the patient's nearest Geisinger urgent care location, with information about urgent care
Self-triage chartBehavioural
A chart demonstrating what to do in response to several common conditions where the patient might be compelled to visit the ED
| Study group | Role | What they receive |
|---|---|---|
| Standard practice | No intervention | Patients in this arm will receive the current standard practice AVS. |
| Contact us first | Experimental | Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention. Receives: Behavioral: Contact information |
| Contact us first + urgent care map | Experimental | Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. Receives: Behavioral: Contact information; Behavioral: Urgent care map |
| Contact us first + urgent care map + self-triage | Experimental | Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. This arm will also receive a self-triage chart, with common reasons patients go to the ED and situations where seeking alternative care might be appropriate. Receives: Behavioral: Contact information; Behavioral: Urgent care map; Behavioral: Self-triage chart |
What is being measured
The primary outcome is the main question the study is designed to answer.
Inappropriate ED visits
Visited the ED inappropriately (y/n)
We will apply the NYU algorithm (Ballard et al., 2010) to determine whether an ED visit is inappropriate.
Measured: In the 30 days following the appointment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Mar 2023
- Study start3 Apr 2023
- Primary completion11 Dec 2023
- Study completion11 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Behavior, HealthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 239,841 participants (actual)
Sponsor and investigators
- Lead sponsor
- Geisinger Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amir Goren, Geisinger Clinic
- Investigators
- Amir Goren, PhD, Principal investigator, Geisinger Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05787548
- Sponsor's protocol ID
- 2022-0340
- Status last verified
- Feb 2024
- First submitted
- 8 Mar 2023
- Last updated
- 26 Feb 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.
Study at a glance
From the registry record, last updated by the sponsor on 26 Feb 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reducing Emergency Department Utilization With an After Visit Summary Nudge Toward Alternative Care Options
- ClinicalTrials.gov ID
- NCT05787548
- Acronym / sponsor ID
- 2022-0340
- Conditions
- Behavior, Health
- Keywords
- Emergency Department Use, Urgent Care Use
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 239,841 participants (actual)
- Lead sponsor
- Geisinger ClinicUniversity, hospital or other
- Study start
- 3 Apr 2023 (actual)
- Primary completion
- 11 Dec 2023 (actual)
- Study completion
- 11 Dec 2023 (actual)
- First posted
- 28 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. The study team is working to reduce ED utilization by including additional information in adult outpatient After Visit Summaries (AVSs). The study will involve will involve A/B testing different AVS versions, including 1) a version that encourages patients to contact Geisinger via different contact methods, 2) a version that includes a map to the patient's closest ConvenientCare location and accompanying information about ConvenientCare, and 3) a version that includes a self-triage guide. A control group will receive the current standard AVS. Analysis results will be assessed to determine which version is most effective at reducing ED use.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Standard practice | No intervention | –Patients in this arm will receive the current standard practice AVS. |
| Contact us first | Experimental | Behavioral: Contact informationPatients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention. |
| Contact us first + urgent care map | Experimental | Behavioral: Contact information, Behavioral: Urgent care mapPatients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. |
| Contact us first + urgent care map + self-triage | Experimental | Behavioral: Contact information, Behavioral: Urgent care map, Behavioral: Self-triage chartPatients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. This arm will also receive a self-triage chart, with common reasons patients go to the ED and situations where seeking alternative care might be appropriate. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age 18+
- Has a Geisinger Primary Care Physician assigned
- Completes an outpatient office visit or telemedicine appointment at Geisinger
Key exclusion criteria (1 listed)
- The AVS was not printed according to the EHR, and the patient does not have an active MyGeisinger patient portal account, so they do not have a way to view the AVS
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Contact informationInformation on how to contact Geisinger if the patient needs care | Behavioural | Contact us first, Contact us first + urgent care map, Contact us first + urgent care map + self-triage |
| Urgent care mapA map of the patient's nearest Geisinger urgent care location, with information about urgent care | Behavioural | Contact us first + urgent care map, Contact us first + urgent care map + self-triage |
| Self-triage chartA chart demonstrating what to do in response to several common conditions where the patient might be compelled to visit the ED | Behavioural | Contact us first + urgent care map + self-triage |
Primary outcome
Inappropriate ED visits
Time frame: In the 30 days following the appointment
Visited the ED inappropriately (y/n) We will apply the NYU algorithm (Ballard et al., 2010) to determine whether an ED visit is inappropriate.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Feb 2024.
- Individual participant dataSharing planned: Yes. Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.
Related trials for Behavior, Health
Not yet recruiting
A Hybrid Effectiveness-Implementation and Cost-Utility Evaluation of a Support Programme for Informal Carers of People With Dementia in Primary Care (EsCuidar2)
Quality of Life
Recruiting
The Sleep2BWell Trial
Blood Pressure, Sleep Health
Active, not recruitingObservational study
Gulf Long-Term Follow-Up Study
Cardiovascular Disease, Hematologic Diseases
Not yet recruiting
Supporting Health and Empowerment Through Contingency Management and Affect Regulation
HIV Risk
Recruiting
Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN)
Cardiovascular Diseases (CVD), Metabolic Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Amir Goren, PhD principal investigator
Geisinger Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Contact information, Urgent care map and Self-triage chart in people with Behavior, Health, run by Geisinger Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Inappropriate ED visits (time frame: In the 30 days following the appointment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2024.